- Home
- ACHV vs JSPR Comparison
ACHV vs JSPR Comparison
Compare ACHV & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- JSPR
- Stock Information
- Founded
- ACHV N/A
- JSPR 2018
- Country
- ACHV United States
- JSPR United States
- Employees
- ACHV N/A
- JSPR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACHV Health Care
- JSPR Health Care
- Exchange
- ACHV Nasdaq
- JSPR Nasdaq
- Market Cap
- ACHV 72.5M
- JSPR 85.8M
- IPO Year
- ACHV N/A
- JSPR N/A
- Fundamental
- Price
- ACHV $2.26
- JSPR $6.82
- Analyst Decision
- ACHV Strong Buy
- JSPR Strong Buy
- Analyst Count
- ACHV 3
- JSPR 10
- Target Price
- ACHV $14.33
- JSPR $62.22
- AVG Volume (30 Days)
- ACHV 1.2M
- JSPR 369.8K
- Earning Date
- ACHV 08-12-2025
- JSPR 08-12-2025
- Dividend Yield
- ACHV N/A
- JSPR N/A
- EPS Growth
- ACHV N/A
- JSPR N/A
- EPS
- ACHV N/A
- JSPR N/A
- Revenue
- ACHV N/A
- JSPR N/A
- Revenue This Year
- ACHV N/A
- JSPR N/A
- Revenue Next Year
- ACHV N/A
- JSPR N/A
- P/E Ratio
- ACHV N/A
- JSPR N/A
- Revenue Growth
- ACHV N/A
- JSPR N/A
- 52 Week Low
- ACHV $1.84
- JSPR $3.13
- 52 Week High
- ACHV $5.31
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- ACHV 35.12
- JSPR 72.52
- Support Level
- ACHV $2.00
- JSPR $5.35
- Resistance Level
- ACHV $3.90
- JSPR $5.72
- Average True Range (ATR)
- ACHV 0.28
- JSPR 0.51
- MACD
- ACHV -0.18
- JSPR 0.07
- Stochastic Oscillator
- ACHV 13.68
- JSPR 97.40
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.